We are striving to extend survival in some of the most aggressive forms of cancer.

In 2000, Yoram Palti, our founder and professor emeritus of physiology and biophysics at the Technion — Israel Institute of Technology, sought to leverage his expertise in biophysics to develop a new way to treat solid tumor cancers that would destroy tumor cells while sparing healthy tissue and avoiding many of the life-altering side effects of existing cancer therapies.

He set up a laboratory in his basement to explore the potential of electric fields as a treatment for solid tumors.

Professor Palti founded Novocure to provide patients with a new cancer treatment based on his hypothesis, since proven, that alternating electric fields, when applied at specific frequencies, can disrupt cancer cell division. This innovative treatment, Tumor Treating Fields, is a completely different approach to cancer therapy.

“Nobody understood what I was doing,” Professor Palti said of his early development of Tumor Treating Fields.

Palti’s initial research from his basement laboratory evolved to become Novocure – an international oncology company with more than 1,300 employees and operations in North America, Europe, the Middle East and Asia.

Our company began with a patient-forward approach that continues to drive our mission today. With more than 20 years of research and many significant milestones, we believe we are only beginning.

Aspiring to make a difference in cancer, from day one

our mission:

Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy.

our vision:

Patient-forward: aspiring to make a difference in cancer

our values
Innovation. Focus. Drive. Courage. Trust. Empathy. Our values are part of who we are and the work we do every day on our patient-forward mission.
https://www.novocure.com/wp-content/uploads/2021/11/8307b63006f5016cdb2fb34ea18c19f5f19abce9.png

leadership at Novocure

Our leaders have extensive experience across oncology, biotechnology and medical device industries.

Leadership
https://www.novocure.com/wp-content/uploads/2023/09/ZZZ_9695-1024x681.jpg

diversity, equity
and inclusion

We are united in our mission to extend survival in some of the most aggressive forms of cancer. A diverse and inclusive workplace empowers our employees to deliver innovative solutions to the challenges inherent in our mission.

learn more
https://www.novocure.com/wp-content/uploads/2021/11/eda5e05130a60ab09f503d3ccebab5c3e31f8914.png

corporate presentation

Learn more about us in our corporate presentation.

 

view presentation